| Jorge M Diego, MD | |
|
2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176-8580 | |
| (317) 398-0121 | |
| Not Available |
| Full Name | Jorge M Diego |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 35 Years |
| Location | 2451 Intelliplex Dr Ste 260, Shelbyville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669400198 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 01077464A (Indiana) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 01077464A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Major Hospital | Shelbyville, IN | Hospital |
| Rush Memorial Hospital | Rushville, IN | Hospital |
| Decatur County Memorial Hospital | Greensburg, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney Specialty Center Inc | 2567628720 | 3 |
| Major Multispecialty Associates | 6305997842 | 44 |
News Archive
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).
Stereotypes about the superior color sense of women may well be rooted in genetics. Brian Verrelli, a researcher at the Biodesign Institute at ASU, is co-collaborator on a study suggesting that natural genetic selection has provided women with a frequent ability to better discriminate between colors than men.
Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2.
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin-), according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
| Entity Name | Kidney Specialty Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679832679 PECOS PAC ID: 2567628720 Enrollment ID: O20120717000182 |
News Archive
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).
Stereotypes about the superior color sense of women may well be rooted in genetics. Brian Verrelli, a researcher at the Biodesign Institute at ASU, is co-collaborator on a study suggesting that natural genetic selection has provided women with a frequent ability to better discriminate between colors than men.
Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2.
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin-), according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jorge M Diego, MD 2451 Intelliplex Dr, Ste 260, Shelbyville, IN 46176-8580 Ph: (305) 243-4664 | Jorge M Diego, MD 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176-8580 Ph: (317) 398-0121 |
News Archive
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).
Stereotypes about the superior color sense of women may well be rooted in genetics. Brian Verrelli, a researcher at the Biodesign Institute at ASU, is co-collaborator on a study suggesting that natural genetic selection has provided women with a frequent ability to better discriminate between colors than men.
Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2.
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin-), according to new research from The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
Anupama Mohanram, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 210, Shelbyville, IN 46176 Phone: 317-421-2012 | |
Whitney E Burchfield, AG-ACNP, BC Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2451 Intelliplex Dr, Shelbyville, IN 46176 Phone: 317-392-3211 Fax: 317-398-1851 | |
R Gregory Scheible, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-0538 | |
Nancy R Miles, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 Fax: 317-398-0538 | |
Lamberto V Abeleda, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2158 Intelliplex Drive, Suite 200, Shelbyville, IN 46176 Phone: 317-392-3651 Fax: 317-398-0538 | |
Stina Wedlock, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2451 Intelliplex Dr Ste 260, Shelbyville, IN 46176 Phone: 317-398-0121 | |
Douglas Carter, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 150 W Washington St, Shelbyville, IN 46176 Phone: 317-392-3211 Fax: 317-398-1851 |